Pharmaceuticals in France
![](/i/report_cover/4228/Industry_Profile_Cover.jpg)
Pharmaceuticals in France
SUMMARY
Pharmaceuticals in France industry profile provides top-line qualitative and quantitative summary information including: market share, market size (value 2015-19, and forecast to 2024). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.
KEY HIGHLIGHTS
SUMMARY
Pharmaceuticals in France industry profile provides top-line qualitative and quantitative summary information including: market share, market size (value 2015-19, and forecast to 2024). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.
KEY HIGHLIGHTS
- The pharmaceuticals market consists of ethical drugs only and does not include consumer healthcare or animal healthcare.
- The French pharmaceuticals market had total revenues of $32,490.0m in 2019, representing a compound annual rate of change (CARC) of -1.5% between 2015 and 2019.
- The French government’s decision to increase its focus on the use of generic medicines to reduce healthcare spending has resulted in decreasing volumes and a downward pricing pressure on existing drugs.
- Reimbursement is based on external reference pricing linked to other EU countries, such as the UK’s NHS. Price reduction in these countries is immediately reflected in the price reductions in France, which has resulted in decreased healthcare spending and a declining pharmaceutical market.
- Save time carrying out entry-level research by identifying the size, growth, and leading players in the pharmaceuticals market in France
- Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the pharmaceuticals market in France
- Leading company profiles reveal details of key pharmaceuticals market players’ global operations and financial performance
- Add weight to presentations and pitches by understanding the future growth prospects of the France pharmaceuticals market with five year forecasts
- What was the size of the France pharmaceuticals market by value in 2019?
- What will be the size of the France pharmaceuticals market in 2024?
- What factors are affecting the strength of competition in the France pharmaceuticals market?
- How has the market performed over the last five years?
- Who are the top competitiors in France's pharmaceuticals market?
1 EXECUTIVE SUMMARY
1.1. Market value
1.2. Market value forecast
1.3. Geography segmentation
1.4. Market share
1.5. Market rivalry
1.6. Competitive Landscape
2 MARKET OVERVIEW
2.1. Market definition
2.2. Market analysis
3 MARKET DATA
3.1. Market value
4 MARKET SEGMENTATION
4.1. Geography segmentation
5 MARKET OUTLOOK
5.1. Market value forecast
6 FIVE FORCES ANALYSIS
6.1. Summary
6.2. Buyer power
6.3. Supplier power
6.4. New entrants
6.5. Threat of substitutes
6.6. Degree of rivalry
7 COMPETITIVE LANDSCAPE
7.1. Market share
7.2. Who are the leading players?
7.3. What strategies do leading players follow?
7.4. What has been the rationale behind recent partnerships?
7.5. Are there any threats towards leading players?
8 COMPANY PROFILES
8.1. Sanofi SA
8.2. Les Laboratoires Servier
8.3. AstraZeneca AB
8.4. Laboratoires Pierre Fabre SA
9 MACROECONOMIC INDICATORS
9.1. Country data
10 APPENDIX
10.1. Methodology
10.2. Industry associations
10.3. Related MarketLine research
10.4. About MarketLine
1.1. Market value
1.2. Market value forecast
1.3. Geography segmentation
1.4. Market share
1.5. Market rivalry
1.6. Competitive Landscape
2 MARKET OVERVIEW
2.1. Market definition
2.2. Market analysis
3 MARKET DATA
3.1. Market value
4 MARKET SEGMENTATION
4.1. Geography segmentation
5 MARKET OUTLOOK
5.1. Market value forecast
6 FIVE FORCES ANALYSIS
6.1. Summary
6.2. Buyer power
6.3. Supplier power
6.4. New entrants
6.5. Threat of substitutes
6.6. Degree of rivalry
7 COMPETITIVE LANDSCAPE
7.1. Market share
7.2. Who are the leading players?
7.3. What strategies do leading players follow?
7.4. What has been the rationale behind recent partnerships?
7.5. Are there any threats towards leading players?
8 COMPANY PROFILES
8.1. Sanofi SA
8.2. Les Laboratoires Servier
8.3. AstraZeneca AB
8.4. Laboratoires Pierre Fabre SA
9 MACROECONOMIC INDICATORS
9.1. Country data
10 APPENDIX
10.1. Methodology
10.2. Industry associations
10.3. Related MarketLine research
10.4. About MarketLine
LIST OF TABLES
Table 1: France pharmaceuticals market value: $ billion, 2015-19
Table 2: France pharmaceuticals market geography segmentation: $ billion, 2019
Table 3: France pharmaceuticals market value forecast: $ billion, 2019-24
Table 4: France pharmaceuticals market share: % share, by value, 2019
Table 5: Sanofi SA: key facts
Table 6: Sanofi SA: Annual Financial Ratios
Table 7: Sanofi SA: Key Employees
Table 8: Sanofi SA: Key Employees Continued
Table 9: Les Laboratoires Servier: key facts
Table 10: Les Laboratoires Servier: Key Employees
Table 11: AstraZeneca AB: key facts
Table 12: AstraZeneca AB: Key Employees
Table 13: Laboratoires Pierre Fabre SA: key facts
Table 14: Laboratoires Pierre Fabre SA: Key Employees
Table 15: France size of population (million), 2015-19
Table 16: France gdp (constant 2005 prices, $ billion), 2015-19
Table 17: France gdp (current prices, $ billion), 2015-19
Table 18: France inflation, 2015-19
Table 19: France consumer price index (absolute), 2015-19
Table 20: France exchange rate, 2015-19
Table 1: France pharmaceuticals market value: $ billion, 2015-19
Table 2: France pharmaceuticals market geography segmentation: $ billion, 2019
Table 3: France pharmaceuticals market value forecast: $ billion, 2019-24
Table 4: France pharmaceuticals market share: % share, by value, 2019
Table 5: Sanofi SA: key facts
Table 6: Sanofi SA: Annual Financial Ratios
Table 7: Sanofi SA: Key Employees
Table 8: Sanofi SA: Key Employees Continued
Table 9: Les Laboratoires Servier: key facts
Table 10: Les Laboratoires Servier: Key Employees
Table 11: AstraZeneca AB: key facts
Table 12: AstraZeneca AB: Key Employees
Table 13: Laboratoires Pierre Fabre SA: key facts
Table 14: Laboratoires Pierre Fabre SA: Key Employees
Table 15: France size of population (million), 2015-19
Table 16: France gdp (constant 2005 prices, $ billion), 2015-19
Table 17: France gdp (current prices, $ billion), 2015-19
Table 18: France inflation, 2015-19
Table 19: France consumer price index (absolute), 2015-19
Table 20: France exchange rate, 2015-19
LIST OF FIGURES
Figure 1: France pharmaceuticals market value: $ billion, 2015-19
Figure 2: France pharmaceuticals market geography segmentation: % share, by value, 2019
Figure 3: France pharmaceuticals market value forecast: $ billion, 2019-24
Figure 4: Forces driving competition in the pharmaceuticals market in France, 2019
Figure 5: Drivers of buyer power in the pharmaceuticals market in France, 2019
Figure 6: Drivers of supplier power in the pharmaceuticals market in France, 2019
Figure 7: Factors influencing the likelihood of new entrants in the pharmaceuticals market in France, 2019
Figure 8: Factors influencing the threat of substitutes in the pharmaceuticals market in France, 2019
Figure 9: Drivers of degree of rivalry in the pharmaceuticals market in France, 2019
Figure 10: France pharmaceuticals market share: % share, by value, 2019
Figure 1: France pharmaceuticals market value: $ billion, 2015-19
Figure 2: France pharmaceuticals market geography segmentation: % share, by value, 2019
Figure 3: France pharmaceuticals market value forecast: $ billion, 2019-24
Figure 4: Forces driving competition in the pharmaceuticals market in France, 2019
Figure 5: Drivers of buyer power in the pharmaceuticals market in France, 2019
Figure 6: Drivers of supplier power in the pharmaceuticals market in France, 2019
Figure 7: Factors influencing the likelihood of new entrants in the pharmaceuticals market in France, 2019
Figure 8: Factors influencing the threat of substitutes in the pharmaceuticals market in France, 2019
Figure 9: Drivers of degree of rivalry in the pharmaceuticals market in France, 2019
Figure 10: France pharmaceuticals market share: % share, by value, 2019